We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

42 hedge funds and large institutions have $129M invested in Tempest Therapeutics in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 7

8% more capital invested

Capital invested by funds: $120M → $129M (+$9.24M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 45 → 42 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
42
Holders Change
-3
Holders Change %
-6.67%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
21
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.53M
2
KCM
Kingdon Capital Management
New York
+$1.32M
3
EA
Emerald Advisers
Pennsylvania
+$1.01M
4
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$684K
5
JHIU
Janus Henderson Investors US
Colorado
+$566K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$1.41M
2
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
-$1.2M
3
Jennison Associates
Jennison Associates
New York
-$424K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$377K
5
Citigroup
Citigroup
New York
-$236K
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
26
Sophrosyne Capital
New York
$510K – – –
Bank of New York Mellon
27
Bank of New York Mellon
New York
$457K +$141K +6 +55%
BIM
28
BlackRock Investment Management
Delaware
$446K +$141K +6 +55%
BGA
29
Belmont Global Advisors
Texas
$321K +$283K +12 New
PAM
30
Panagora Asset Management
Massachusetts
$274K +$94.3K +4 +67%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$258K +$70.7K +3 +43%
BCM
32
Bridgeway Capital Management
Texas
$229K – – –
Charles Schwab
33
Charles Schwab
California
$221K +$94.3K +4 +100%
TA
34
Teachers Advisors
New York
$194K +$70.7K +3 +75%
BA
35
BlackRock Advisors
Delaware
$168K – – –
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$163K +$141K +6 New
NFA
37
Nationwide Fund Advisors
Ohio
$104K +$23.6K +1 +33%
AIG
38
American International Group
New York
$92.6K +$23.6K +1 +50%
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$68K +$70.7K +3 New
Morgan Stanley
40
Morgan Stanley
New York
$47K -$236K -10 -83%
U
41
UBS
Switzerland
$38K – – –
BRWM
42
B. Riley Wealth Management
Tennessee
$17K – – –
AllianceBernstein
43
AllianceBernstein
Tennessee
$13K – – –
VFA
44
Virtus Fund Advisers
Connecticut
$12K – – –
Wells Fargo
45
Wells Fargo
California
$10K – – –
WEC
46
Winslow Evans & Crocker
Massachusetts
$9.17K – – –
Citigroup
47
Citigroup
New York
$6K -$236K -10 Closed
BJ
48
BlackRock Japan
Japan
$4K – – –
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$3.98K – – –
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K -$23.6K -1 Closed
1
2
3

TPST Hedge Fund Activity: Q2 2014 in Review

42 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q2 2014, worth a combined $129M — up 7.7% from $120M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of TPST and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 21 added.

The largest buyer was Adage Capital Partners, adding an estimated $1.53M. The largest seller was Sabby Management, cutting an estimated $1.41M.

  • 42 institutional investors held Tempest Therapeutics (TPST) as of Q2 2014, down from 45 in Q1 2014.
  • Funds reported $129M of Tempest Therapeutics stock for Q2 2014, up 7.7% quarter-over-quarter.
  • 3 funds opened new Tempest Therapeutics positions in Q2 2014 and 6 closed out, a net change of -3 holders.
  • The largest Tempest Therapeutics buyer in Q2 2014 was Adage Capital Partners, an estimated $1.53M added.
  • The largest Tempest Therapeutics seller in Q2 2014 was Sabby Management, an estimated $1.41M sold.

Based on aggregated 13F filings for Q2 2014.